Associated Papers
Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors.
Yang D et al.
Cancer Communications (london, England), 2021
Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers.
Tao Z et al.
Frontiers in Oncology, 2021
34650924 (PubMed )
Supplement: DataSheet_1.xlsx › mutation_list
Select a paper to view details